Table S7 from <i>NF1</i> Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in <i>NF1</i>-Mutant Melanoma

Authors

Irineu Illa-Bochaca (ORCID: https://orcid.org/0000-0002-8039-565X)
Kelly V. Ruggles (ORCID: https://orcid.org/0000-0002-0152-0863)
Markus Schöber (ORCID: https://orcid.org/0000-0002-9122-2121)
Milad Ibrahim (ORCID: https://orcid.org/0000-0001-8841-7393)
Eleazar Vega‐Saenz de Miera (ORCID: https://orcid.org/0000-0001-8443-1286)
George Jour (ORCID: https://orcid.org/0000-0001-8916-8966)
Iman Osman (ORCID: https://orcid.org/0000-0002-1472-1971)
Joseph Fracasso

Publication Details

Published: 2025-09-02
DOI: https://doi.org/10.1158/0008-5472.30029852
Primary Topic: Melanoma and MAPK Pathways
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Table S7 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

Irineu Illa-Bochaca, Kelly V. Ruggles, Markus Schöber, Milad Ibrahim et al.

Sep 2, 2025

Melanoma and MAPK Pathways

article

Table S7 from NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1-Mutant Melanoma

Irineu Illa-Bochaca, Kelly V. Ruggles, Markus Schöber, Milad Ibrahim, Eleazar Vega‐Saenz de Miera, George Jour, Iman Osman, Joseph Fracasso

September 2, 2025article en

Abstract

No abstract available for this paper.

Openalex Percentile: Top 80%

Melanoma and MAPK Pathways

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Table S7 from <i>NF1</i> Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in <i>NF1</i>-Mutant Melanoma — Irineu Illa-Bochaca, Kelly V. Ruggles, et al. · (2025) | TGRS Research Map | TGRS